105 related articles for article (PubMed ID: 40773)
1. Metabolic fate of phenobarbital in man. N-Glucoside formation.
Tang BK; Kalow W; Grey AA
Drug Metab Dispos; 1979; 7(5):315-8. PubMed ID: 40773
[TBL] [Abstract][Full Text] [Related]
2. Metabolic fate of phenobarbital. A quantitative study of p-hydroxyphenobarbital elimination in man.
Whyte MP; Dekaban AS
Drug Metab Dispos; 1977; 5(1):63-70. PubMed ID: 13977
[TBL] [Abstract][Full Text] [Related]
3. Identification of phenobarbital N-glucuronides as urinary metabolites of phenobarbital in mice.
Neighbors SM; Soine WH
Drug Metab Dispos; 1995 May; 23(5):548-52. PubMed ID: 7587929
[TBL] [Abstract][Full Text] [Related]
4. Determination of phenobarbital, p-hydroxyphenobarbital and phenobarbital-N-glucoside in urine by gas chromatography chemical ionization mass spectrometry.
Tang BK; Yilmaz B; Kalow W
Biomed Mass Spectrom; 1984 Sep; 11(9):462-5. PubMed ID: 6509155
[TBL] [Abstract][Full Text] [Related]
5. Metabolism, pharmacokinetics, and excretion of the substance P receptor antagonist CP-122,721 in humans: structural characterization of the novel major circulating metabolite 5-trifluoromethoxy salicylic acid by high-performance liquid chromatography-tandem mass spectrometry and NMR spectroscopy.
Colizza K; Awad M; Kamel A
Drug Metab Dispos; 2007 Jun; 35(6):884-97. PubMed ID: 17360832
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of phenobarbital and p-hydroxyphenobarbital and their stable isotope labeled analogs by gas chromatography mass spectrometry.
Van Langenhove A; Biller JE; Biemann K; Browne TR
Biomed Mass Spectrom; 1982 May; 9(5):201-7. PubMed ID: 7093441
[TBL] [Abstract][Full Text] [Related]
7. Disposition and metabolism of radiolabeled casopitant in humans.
Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
[TBL] [Abstract][Full Text] [Related]
8. N-Hydroxylation of pentobarbital in man.
Tang BK; Inaba T; Kalow W
Drug Metab Dispos; 1977; 5(1):71-4. PubMed ID: 13978
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of bepridil in laboratory animals and humans.
Wu WN; Hills JF; Chang SY; Ng KT
Drug Metab Dispos; 1988; 16(1):69-77. PubMed ID: 2894958
[TBL] [Abstract][Full Text] [Related]
10. N-hydroxyamobarbital: the second major metabolite of amobarbital in man.
Tang BK; Inaba T; Kalow W
Drug Metab Dispos; 1975; 3(6):479-86. PubMed ID: 1222
[TBL] [Abstract][Full Text] [Related]
11. LC determination of the diastereomers of 1-(beta-D-glucopyranosyl)phenobarbital in human urine.
Soine WH; Soine PJ; England TM; Welty DF; Wood JH
J Pharm Biomed Anal; 1990; 8(4):365-72. PubMed ID: 2100211
[TBL] [Abstract][Full Text] [Related]
12. Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.
Prakash C; Cui D; Baxter JG; Bright GM; Miceli J; Wilner K
Drug Metab Dispos; 1998 May; 26(5):448-56. PubMed ID: 9571226
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of the antianxiety drug buspirone in human subjects.
Jajoo HK; Mayol RF; LaBudde JA; Blair IA
Drug Metab Dispos; 1989; 17(6):634-40. PubMed ID: 2575499
[TBL] [Abstract][Full Text] [Related]
14. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD
Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226
[TBL] [Abstract][Full Text] [Related]
15. Amobarbital metabolism in man: N-glucoside formation.
Tang BK; Kalow W; Grey AA
Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):45-53. PubMed ID: 684279
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and disposition of a potent and selective GABA-Aalpha2/3 receptor agonist in healthy male volunteers.
Polsky-Fisher SL; Vickers S; Cui D; Subramanian R; Arison BH; Agrawal NG; Goel TV; Vessey LK; Murphy MG; Lasseter KC; Simpson RC; Vega JM; Rodrigues AD
Drug Metab Dispos; 2006 Jun; 34(6):1004-11. PubMed ID: 16510541
[TBL] [Abstract][Full Text] [Related]
17. Excretion and metabolism of the antihypertensive agent, RWJ-26240 (McN-5691) in dogs.
Wu WN; Masucci JA; Caldwell GW; Carson JR
Drug Metab Dispos; 1998 Feb; 26(2):115-25. PubMed ID: 9456297
[TBL] [Abstract][Full Text] [Related]
18. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
Prakash C; Kamel A; Gummerus J; Wilner K
Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
[TBL] [Abstract][Full Text] [Related]
19. Disposition and metabolism of finasteride in dogs.
Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
[TBL] [Abstract][Full Text] [Related]
20. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
